Clinical Trial Update: DCs Vaccine Combined With Cytokine-induced Killer Cells in Patients With AML [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial updating recruitment for a combination therapy using dendritic cell vaccine and cytokine-induced killer cells in patients with acute my…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Cytokine-induced killer cells
• Dendritic cell vaccine

Snippet

Sponsor: Affiliated Hospital to Academy of Military Medical Sciences | Conditions: High-risk Soft Tissue Sarcoma | Phase 1, Phase 2 | Status: RECRUITING